68Ga-NYM005 injection: Clinical Trials

1 trial of 68Ga-NYM005 injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow 68Ga-NYM005 injection: new trials by email Literature Review of 68Ga-NYM005 injection trials Research Report on 68Ga-NYM005 injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients
68Ga-NYM005 injection - Clear Cell Renal Cell Carcinoma Metastatic
Phase 1 / Phase 2CompletedNorroy Bioscience Co., LTD192024-06-172025-05-21

Conditions studied

Clear-cell metastatic renal cell carcinoma (1)

Sponsors

Norroy Bioscience Co., LTD (1)

Countries

China (1)